Researchers from the University of California at San Diego School of Medicine are reporting on their efforts to embed chemotherapy drugs within tumor targeting nanoparticles.
From the abstract in PNAS:
We designed an ανβ3-targeted nanoparticle (NP) encapsulating the cytotoxic drug doxorubicin (Dox) for targeted drug delivery to the ανβ3-expressing tumor vasculature. We observed real-time targeting of this NP to tumor vessels and noted selective apoptosis in regions of the ανβ3-expressing tumor vasculature. In clinically relevant pancreatic and renal cell orthotopic models of spontaneous metastasis, targeted delivery of Dox produced an antimetastatic effect. In fact, ανβ3-mediated delivery of this drug to the tumor vasculature resulted in a 15-fold increase in antimetastatic activity without producing drug-associated weight loss as observed with systemic administration of the free drug.
Press release: “Smart Bomb” Nanoparticle Strategy Impacts Metastasis…
Abstract in PNAS…
More in WIRED…
